In vitro cytotoxicity of silver nanoparticles in primary rat hepatic stellate cells

Molecular Medicine Reports

Volumn 8, Issue 5, 2013, Pages 1365-1372

  Sun, Xiaojing ^a   Wang, Zhiming ^a   Zhai, Shengyong ^b   Cheng, Yingwen ^c   Liu, Jie ^c   Liu, Binbin ^a  

^a FUDAN UNIVERSITY   (China)

^b WEIFANG PEOPLE'S HOSPITAL   (China)

^c DUKE UNIVERSITY   (United States)

Author keywords

Cytotoxicity; Dose dependent; Hepatic stellate cells; Silver nanoparticles; Size dependent

Indexed keywords

SILVER NANOPARTICLE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL METABOLISM; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IN VITRO STUDY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; NONHUMAN; RAT; STELLATE CELL; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATIC STELLATE CELLS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; RATS; SILVER;

EID: 84885165627     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1683     Document Type: Article

References (20)

1. AshaRani PV, Low Kah Mun G, Hande MP and Valiyaveettil S: Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3: 279-290, 2009.
2. Xu X, Yang Q, Bai J, Lu T, Li Y and Jing X: Fabrication of biodegradable electrospun poly(L-lactide-co-glycolide) fibers with antimicrobial nanosilver particles. J Nanosci Nanotechno 8: 5066-5070, 2008.
3. Lu L, Sun RW, Chen R, Hui CK, Ho CM, Luk JM, Lau GK and Che CM: Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther 13: 253-262, 2008.
4. Schroeder S, Heller DA, Winslow MM, et al. Treating metastatic cancer with nanotechnology. Nat Rev Cancer 12: 39-50, 2011.
5. Weiskirchen R and Gressner AM: Isolation and culture of hepatic stellate cells. Methods Mol Med 117: 99-113, 2005.
6. Lara HH, Ayala-Nuñez NV and Ixtepan-Turrent L and Rodriguez-Padilla C: Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnology 8: 1-10, 2010.
7. Gopinath P, Gogoi SK, Chattopadhyay A and Ghosh SS: Implications of silver nanoparticle induced cell apoptosis for in vitro gene therapy. Nanotechnology 19: 104-113, 2008.
8. Yuan Y, Liu C, Qian J, Wang J and Zhang Y: Size-mediated cytotoxicity and apoptosis of hydroxyapatite nanoparticles in human hepatoma HepG2 cells. Biomaterials 31: 730-740, 2010.
9. Abdelhalim MA and Jarrar BM: Gold nanoparticles induced cloudy swelling to hydropic degeneration, cytoplasmic hyaline vacuolation, polymorphism, binucleation, karyopyknosis, karyolysis, karyorrhexis and necrosis in the liver. Lipids Health Dis 10: 166, 2011.
10. 2 nanowire-induced cytotoxicity in Hela cells. J Nanosci Nanotechnol 10: 397-404, 2010.
11. Zamzami N and Kroemer G: Condensed matter in cell death. Nature 401: 127-128, 1999.
12. Urne AG and Vaux DL: Molecular and clinical aspects of apoptosis. Pharmacol Ther 72: 37-50, 1996.
13. Schrand AM, Rahman MF, Hussain SM, Schlager JJ, Smith DA and Syed AF: Metal-based nanoparticles and their toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2: 544-568, 2010.
14. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
15. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssière JL, Petit PX and Kroemer G: Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 181: 1661-1672, 1995.
16. Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi JY, Choi J and Hyun JW: Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 201: 92-100, 2011.
17. Kroemer G, Zamzami N and Susin SA: Mitochondrial control of apoptosis. Immunol Today 18: 44-51, 1997.
18. Chung TW, Kim JR, Suh JI, Lee YC, Chang YC, Chung TH and Kim CH: Correlation between plasma levels of matrix metalloproteinase (MMP)-9/MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus. J Gastroen Hepatol 19: 565-571, 2004.
19. Lichtinghagen R, Huegel O, Seifert T et al: Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C. Clin Chem 46: 183-192, 2000.
20. Chen JS, Wang Q, Fu XH, Huang XH, Chen XL, Cao LQ, Chen LZ, Tan HX, Li W, Bi J and Zhang LJ: Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. Hepatol Res 39: 177-186, 2009.